AngioDynamics, Inc.
ANGO
$10.36
$0.383.81%
NASDAQ
| 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 7.26% | 2.73% | -3.76% | -12.56% | -13.06% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.26% | 2.73% | -3.76% | -12.56% | -13.06% |
| Cost of Revenue | 3.03% | -2.46% | -9.67% | -19.91% | -16.54% |
| Gross Profit | 11.07% | 7.58% | 1.94% | -5.25% | -9.68% |
| SG&A Expenses | 4.70% | 4.98% | 0.99% | -1.21% | -0.05% |
| Depreciation & Amortization | -4.65% | -13.27% | -20.92% | -30.75% | -32.69% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.24% | -0.49% | -6.28% | -12.67% | -10.19% |
| Operating Income | 33.72% | 29.17% | 28.90% | 13.89% | -28.85% |
| Income Before Tax | 88.33% | 86.53% | 82.24% | 78.90% | -2,456.47% |
| Income Tax Expenses | 99.98% | -102.77% | 99.46% | 90.41% | -362.38% |
| Earnings from Continuing Operations | 87.67% | 86.79% | 81.56% | 78.48% | -1,491.96% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 87.67% | 86.79% | 81.56% | 78.48% | -1,491.96% |
| EBIT | 33.72% | 29.17% | 28.90% | 13.89% | -28.85% |
| EBITDA | 97.32% | 78.24% | 80.52% | 8.19% | -222.55% |
| EPS Basic | 87.93% | 87.03% | 81.78% | 78.70% | -1,480.95% |
| Normalized Basic EPS | 48.13% | 43.82% | 45.99% | 37.48% | -15.26% |
| EPS Diluted | 87.86% | 86.97% | 81.71% | 78.60% | -1,476.04% |
| Normalized Diluted EPS | 48.13% | 43.82% | 45.93% | 37.41% | -15.41% |
| Average Basic Shares Outstanding | 1.43% | 1.49% | 1.67% | 1.85% | 1.92% |
| Average Diluted Shares Outstanding | 1.43% | 1.49% | 1.59% | 1.77% | 1.84% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |